Hydroxyzine and Baraclude drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Hydroxyzine (hydroxyzine hydrochloride) and Baraclude (entecavir). Common drug interactions include arthralgia among females and atelectasis among males.
The phase IV clinical study analyzes what interactions people have when they take Hydroxyzine and Baraclude. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Hydroxyzine?
Hydroxyzine has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 54,069 Hydroxyzine users. Check the latest studies of Hydroxyzine.
What is Baraclude?
Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.
11 people who take Hydroxyzine and Baraclude together, and have interactions are studied.

What are the common drug interactions of Hydroxyzine and Baraclude, by gender? *:
female:
- Arthralgia (joint pain)
- Chronic kidney disease
- Completed suicide (act of taking one's own life)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Headache (pain in head)
- Influenza like illness
- Nausea (feeling of having an urge to vomit)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Psoriasis (immune-mediated disease that affects the skin)
male:
- Atelectasis (partial or complete collapse of the lung)
- Blood urea increased
- Vision blurred
- Chest discomfort
- Chest pain
- Death
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Haematocrit decreased
- Haemoglobin decreased
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
What are the common drug interactions of Hydroxyzine and Baraclude, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chronic kidney disease
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Renal injury (kidney injury)
40-49:
- Arthralgia (joint pain)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Headache (pain in head)
- Influenza like illness
- Nausea (feeling of having an urge to vomit)
- Psoriasis (immune-mediated disease that affects the skin)
- Serum sickness-like reaction
50-59:
- Completed suicide (act of taking one's own life)
60+:
- Atelectasis (partial or complete collapse of the lung)
- Blood urea increased
- Vision blurred
- Chest discomfort
- Chest pain
- Death
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Haematocrit decreased
- Haemoglobin decreased
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
What are the existing conditions these people have? *
- Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 3 people, 27.27%
- Constipation: 2 people, 18.18%
- Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%
- Bipolar Disorder (mood disorder): 1 person, 9.09%
- Cough: 1 person, 9.09%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 9.09%
- Dyspnea (difficult or laboured breathing): 1 person, 9.09%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 9.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
- Headache (pain in head): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Hydroxyzine and Baraclude?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Hydroxyzine (54,069 reports)
- Baraclude (6,175 reports)
Browse all drug interactions of Hydroxyzine and Baraclude:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Hydroxyzine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Baraclude:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hydroxyzine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Baraclude and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on hydroxyzine hydrochloride and entecavir (the active ingredients of Hydroxyzine and Baraclude, respectively), and Hydroxyzine and Baraclude (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Apixaban and Spiriva Respimat - 2 seconds ago
- Could Methylprednisolone cause Rhinovirus Infection? - 9 seconds ago
- Liver Injury and drugs of ingredients of pravastatin sodium - 16 seconds ago
- Could Symbicort cause Chest X-Ray Abnormal? - 19 seconds ago
- Drug interactions of Transderm Scop and Humalog - 23 seconds ago
- Abdominal Abscess and drugs of ingredients of nitroglycerin - 27 seconds ago
- Cardiac Failure and Blood Creatine Phosphokinase Increased - 32 seconds ago
- Fragmin and Nosebleed for Men aged 60+ - 46 seconds ago
- Fragmin and Nose Bleeds for Men aged 60+ - 46 seconds ago
- Fragmin and Nosebleeds for Men aged 60+ - 46 seconds ago